Apoptosis in B-cell lymphomas and reactive lymphoid tissues always involves activation of caspase 3 as determined by a new in situ detection method

Journal of Pathology

Volumn 196, Issue 3, 2002, Pages 307-315

  Dukers, Danny F ^a   Oudejans, Joost J ^a   Vos, Wim ^a   ten Berge, Rosita L ^a   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; B cell lymphoma; Burkitt lymphoma; Caspase; Infectious mononucleosis; Lymphocyte; Lymphoma; PARP

Indexed keywords

CASPASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER GRADING; CELL STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ASSAY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LARGE CELL LYMPHOMA; LEUKEMIA CELL LINE; LYMPH NODE BIOPSY; LYMPHOID TISSUE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

APOPTOSIS; BIOLOGICAL MARKERS; BURKITT LYMPHOMA; CASPASE 3; CASPASES; ENZYME ACTIVATION; ENZYME PRECURSORS; HUMANS; IMMUNOHISTOCHEMISTRY; INFECTIOUS MONONUCLEOSIS; JURKAT CELLS; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; POLY(ADP-RIBOSE) POLYMERASES; PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 0036184582     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1046     Document Type: Article

References (43)

1. The central effectors of cell death in the immune system
2. Caspases: Intracellular signalling by proteolysis
3. Bax directly induces release of cytochrome c from isolated mitochondria
4. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
5. P53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2
6. Pro-caspase-3 is a major physiologic target of caspase-8
7. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
8. Granzyme B-mediated cytochrome c release is regulated by the bcl-2 family members bid and Bax
9. Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis
10. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases
11. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases
12. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7
13. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death
14. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis
15. Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model?
16. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
17. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis
18. BCL-2 family. Regulators of cell death
19. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells
20. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases)
21. Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells
22. The tyrosine kinase 1ck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation
23. Purified photoproducts of merocyanine 540 trigger cytochrome C release and caspase 8-dependent apoptosis in human leukemia and melanoma cells
24. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53
25. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction
26. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting Airlie House, Virginia, November 1997
27. Catalyzed reporter deposition, a novel method of signal amplification. I. Application to immunoassays
28. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease
29. A nondenaturing purification scheme for the DNA-binding domain of poly(ADP-ribose) polymerase, a structure-specific DNA-binding protein
30. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes
31. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells
32. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
33. Caspase-3-dependent and -independent degradation of 28 S ribosomal RNA may be involved in the inhibition of protein synthesis during apoptosis initiated by death receptor engagement
34. The BH3 domain is required for caspase-independent cell death induced by Bax and oligomycin
35. Execution of apoptosis: Converging or diverging pathways?
36. Transforming growth factor β induces caspase 3-independent cleavage of αII-spectrin (α-fodrin) coincident with apoptosis
37. Apoptosis induced by TGF-β in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent
38. Inhibition of death receptor signals by cellular FLIP
39. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
40. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation
41. Relationship of p53, bcl-2 and tumour proliferation to clinical drug resistance in non-Hodgkin's lymphomas
42. Myeloma cells selected for resistance to CD-95 mediated apoptosis are not cross-resistant to cytotoxic drugs: Evidence for independent mechanisms of caspase activation
43. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis